Yajie Zhou

Prof. Yajie Zhou

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2026 in Nutrition Reviews
Verified
Journal Article
Closed access
LZLinjie Zhang
Linjie Zhang
Jing SuiJing Sui
Jing Sui
昊王昊 王
昊 王
QZQun Zhao
Qun Zhao
YZYajie Zhou
Yajie Zhou
HXHui Xia
Hui Xia
Context: Chronic liver disease is a major global health burden, and preventive strategies are crucial, given its insidious progression. Although individual nutrients and foods’ associations with chronic liver disease are studied, dietary patterns’ holistic effects matter more. Objective: This study systematically evaluated the links between 2 healthy dietary indices—the Alternative Healthy Eating Index (AHEI) and the Healthy Eating Index (HEI)—and chronic liver disease, namely, metabolic dysfunction–associated steatotic liver disease, liver fibrosis, cirrhosis, fatty liver, and liver cancer. Data Sources: A systematic literature search was conducted in the PubMed, Web of Science, Cochrane Library, and Embase databases for relevant observational studies published up to February 2025. Data Extraction: Data extraction and quality assessment were performed independently by the authors. A total of 28 articles comprising 50 studies (n = 18 prospective cohort, 25 cross-sectional, and 7 case-control studies) involving 624 914 participants were included. Data Analysis: A random-effects model was used for the meta-analysis. Results showed the AHEI (OR = 0.71; 95% CI, 0.62-0.80) and HEI (OR = 0.68; 95% CI, 0.61-0.77) were significantly negatively associated with chronic liver disease. Subgroup analysis found the AHEI protected against MASLD, liver cancer, and overall chronic liver disease, notably in Asia and North America. The HEI protected against MASLD, fibrosis, liver cancer, and chronic liver disease, with marked effects in North America. This study’s strengths lie in its large sample size, integration of multiple study designs, and rigorous methodological framework, which collectively enhance the generalizability of its results. Conclusions: The findings suggest the AHEI and HEI are associated with a lower risk of chronic liver disease, providing valuable guidance for clinical practice, such as advocating for these dietary patterns among high-risk populations. However, limitations exist, including potential heterogeneity in dietary assessment methods and unaccounted confounders. Future research should address these issues to further optimize chronic liver disease management strategies. Systematic Review Registration: PROSPERO registration no. CRD42025065410

Verified
Journal Article
Open access
PDF file
BHBihuan Hu
Bihuan Hu
HXHui Xia
Hui Xia
PTPeixuan Tian
Peixuan Tian
XLXinbao Li
Xinbao Li
YYYu Yang
Yu Yang
Jing SuiJing Sui
Jing Sui
Alcoholic liver disease (ALD) is a type of liver disease with complex pathogenic factors. In 2019, alcohol caused 11 million life-years to be lost globally, and the mortality rate has continued to rise. This study aims to explore the exclusive gene profile of AH and construct an mRNA-lncRNA regulatory network through an integrative analysis and database validation to reveal potential key biomarkers. We obtained expression data for alcoholic hepatitis from the GEO database; screened differentially expressed genes (DEGs) through a weighted gene co-expression network analysis (WGCNA); conducted a GO&KEGG analysis; and focused on the enrichment pathways for the top 20 genes. Hub genes were selected using cytoHubba and MCODE to construct the mRNA-lncRNA regulatory network, and key genes were confirmed using GSE167308 and GSE28619. We obtained 2552 differentially expressed mRNAs and 555 differentially expressed lncRNAs from three databases. Differentially expressed genes are mainly involved in pathways such as lipid metabolism disorders, complement activation, the activation of cancer-related pathways, the excessive activation of inflammatory immunity, and the initiation of cell adhesion and fibrosis. Based on the hub gene analysis, we screened out 43 key genes. By constructing the key mRNA-lncRNA–pathway network, we identified 12 mRNAs (AQP1, ELOVL7, ITPR3, KRT19, KRT23, LAMC2, MMP7, PROM1, SPINT1, STK39, TNFRSF21, and VTCN1) and 14 lncRNAs that play an important role in the occurrence and development of alcoholic hepatitis. To sum up, this article mainly expounds upon the key genes in the occurrence and development of alcoholic hepatitis. The key genes are mainly concentrated within signaling pathways such as metabolic pathways, fatty acid metabolism, and cancer pathways. Twelve differentially expressed mRNAs in the co-expression network can be used as biomarkers and intervention targets for the diagnosis and treatment of alcoholic hepatitis.

14 April 2026 in International Journal for Vitamin and Nutrition Research
Verified
Journal Article
Open access
PDF file
DGDaochen Gong
Daochen Gong
HXHui Xia
Hui Xia
BHBihuan Hu
Bihuan Hu
PTPeixuan Tian
Peixuan Tian
YYYu Yang
Yu Yang
YZYajie Zhou
Yajie Zhou
Background: Cardiovascular disease (CVD) remains a significant global health burden, while carotenoids are considered to have beneficial protective effects against CVD. Thus this study aimed to synthesize available relevant findings regarding the potential correlation between carotenoid consumption (including α/β-carotene, β-cryptoxanthin, lutein, lycopene, zeaxanthin, and astaxanthin) and CVD risk through an umbrella meta-analysis and systematic reviews. Methods: Literature searches were conducted in four online academic databases, including PubMed, Web of Science, Embase, and the Cochrane Library, as well as in the literature reference lists of existing meta-analyses and systematic reviews. The search was completed with a cutoff date of July 2023. Results: The association between carotenoids, including blood, carotenoid intake, and carotenoid supplements, and CVD risk was estimated as an odds ratio (OR) of 0.889 (95% confidence interval (95% CI): 0.857–0.922; p < 0.001), indicating a notable protective association. Furthermore, our analysis demonstrated that the protective impact of carotenoids on total CVD was the most significant for coronary heart disease (OR = 0.875; 95% CI: 0.822–0.932) and stroke (OR = 0.815; 95% CI: 0.734–0.906). Conclusions: By controlling for the confounding effects of heterogeneity, including clinical heterogeneity, methodological heterogeneity, and statistical heterogeneity, and publication bias, including positive result enrichment bias, duplicate publication bias, selective study inclusion bias, and selective bias in data extraction and analysis, etc., this study conducted a methodical assessment of the correlation between carotenoids and clinical outcomes of CVD, demonstrating significant inverse relationships between multiple carotenoids and both CVD incidence and mortality of CVD.

9 September 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
LZLinjie Zhang
Linjie Zhang
Jing SuiJing Sui
Jing Sui
HYHanlin Yin
Hanlin Yin
QZQun Zhao
Qun Zhao
YZYajie Zhou
Yajie Zhou
HXHui Xia
Hui Xia
Conventional research mainly focuses on individual nutrients or specific foods in relation to chronic liver disease, but the cumulative effects of dietary patterns are underexplored. This study aimed to assess current evidence on the alternate Mediterranean Diet (aMED) and chronic liver disease risk via a meta-analysis of observational studies. A systematic search of PubMed, Web of Science, Cochrane, and Embase (up to February 2025) identified studies on aMED and chronic liver disease, using predefined criteria for screening, quality assessment, and data extraction. A total of 20 articles (3 cross-sectional, 15 cohort, and 2 case–control; 1,286,480 participants) were analyzed using a random-effects model. The analysis showed that aMED was significantly negatively correlated with chronic liver disease (OR = 0.65, 95% CI: 0.56–0.75), indicating that adherence reduces risk. Subgroup analysis showed aMED’s protective effects in North America (OR = 0.67, 95% CI: 0.54–0.83) and Europe (OR = 0.54, 95% CI: 0.44–0.66). The results suggest aMED adherence may lower chronic liver disease risk, emphasizing dietary modifications for prevention.

19 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
YCYutong Chen
Yutong Chen
HXHui Xia
Hui Xia
BHBihuan Hu
Bihuan Hu
PTPeixuan Tian
Peixuan Tian
YYYu Yang
Yu Yang
Jing SuiJing Sui
Jing Sui
Background: Chronic obstructive pulmonary disease (COPD) is a global public health issue and a major cause of morbidity and mortality. Meat consumption is considered one of the factors influencing the risk of COPD. This study aims to perform a systematic review and meta-analysis to synthesize evidence on meat consumption and COPD risk. Methods: A systematic review and meta-analysis were performed and reported through a comprehensive search in PubMed and Web of Science from inception to March 2025 (PROSPERO registration ID: CRD42024595137). This meta-analysis included fifteen observational studies. Forest plots were presented, statistical heterogeneity was quantified with the I2 statistic and investigated through subgroup analyses. Funnel plots and Egger’s test were used to evaluate publication bias. Results: The results showed that the odds ratio (OR) for total meat consumption and the risk of COPD was 1.15 (95% confidence interval (CI): 1.01–1.31), suggesting that meat consumption was associated with a higher risk of COPD. Our analysis revealed that fish consumption (OR: 0.84; 95% CI: 0.72–0.97) had a protective effect on COPD risk while processed meat consumption (OR: 1.18; 95% CI: 1.02–1.37) and cured meat consumption (OR: 1.64; 95% CI: 1.41–1.90) was significantly associated with an increased risk of COPD. In addition, subgroup analysis suggested that higher meat consumption was associated with an elevated risk of COPD in cross-sectional study (OR = 1.78; 95% CI: 1.57–2.02), case–control study (OR = 1.52; 95% CI: 1.10–2.10) and in group with 1000 or more participants (OR = 1.16; 95% CI: 1.01–1.33). Conclusions: The pooled results of this meta-analysis suggest an association between total meat consumption (encompassing fish, processed meat, cured meat, and unprocessed meat) and COPD. However, the strength of this evidence is tempered by substantial between-study heterogeneity and inconsistent findings across study designs—notably, cohort data failed to support a significant association. Future research should standardize classifications and explore meat subtypes to address heterogeneity.

1 January 2025 in Integrative Cancer Therapies
Verified
Journal Article
Open access
XLXiaotong Li
Xiaotong Li
AYAnna Ye
Anna Ye
HYHwaseung Yoo
Hwaseung Yoo
JBJerrin Bawa
Jerrin Bawa
LSLingyun Sun
Lingyun Sun
KLKevin T T. Liou
Kevin T T. Liou
Background: Reishi mushroom is one of the most commonly used supplements among cancer patients. However, limited data exists on why patients choose Reishi. This study aimed to explore patients’ expectations and barriers to using Reishi. Methods: We conducted a cross-sectional survey study of a cancer population from Mainland China who reported using Reishi. Participants were recruited using a customer database from Zhongke Health International LLC. Patients’ expectations and barriers to Reishi use were assessed using a modified version of the Attitudes and Beliefs Toward Complementary and Alternative Medicine (ABCAM) survey. Multivariable linear regression models were applied to examine whether socio-demographic and clinical factors, as well as Reishi usage patterns, influenced participants’ attitudes toward Reishi. Results: Among 1374 participants, the most common sources of information about Reishi products were friends (49.78%) and family (36.83%). More than half (55.9%) used additional traditional Chinese herbal remedies in combination with Reishi. The most frequently cited expectations for Reishi use were boosting immunity (45% strongly agreed) and improving physical health (41% strongly agreed). 72% identified cost and insurance coverage as the primary barriers to Reishi usage. Approximately 10% considered side effects and limited research evidence as barriers. Stage IV cancer and duration of Reishi use >5 years were significantly associated with higher expectations and lower perceived barriers. Conclusion: This study identified the most common expectations and barriers to Reishi use in cancer care in Mainland China. These findings can help clinicians better understand patient perspectives and integrate herbal supplements more effectively into supportive cancer care.